These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2111024)
1. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Jehuda-Cohen T; Slade BA; Powell JD; Villinger F; De B; Folks TM; McClure HM; Sell KW; Ahmed-Ansari A Proc Natl Acad Sci U S A; 1990 May; 87(10):3972-6. PubMed ID: 2111024 [TBL] [Abstract][Full Text] [Related]
2. In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants. Pahwa S; Chirmule N; Leombruno C; Lim W; Harper R; Bhalla R; Pahwa R; Nelson RP; Good RA Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7532-6. PubMed ID: 2798424 [TBL] [Abstract][Full Text] [Related]
3. HIV-induced, HIV-specific in vitro antibody response by B-cells from HIV-seropositive individuals. Delfraissy JF; Wallon C; Boué F; Goujard C; Barré-Sinoussi F; Galanaud P AIDS; 1992 Jan; 6(1):55-63. PubMed ID: 1371925 [TBL] [Abstract][Full Text] [Related]
4. In vitro production of HIV-1 specific antibodies from "at risk" seronegative subjects. Quarto M; Fiore JR; Chironna M; Fontana A; Germinario C; Troiano T; Fico C; Congedo P; Grottola A; Monno L Microbiologica; 1992 Jan; 15(1):29-33. PubMed ID: 1556957 [TBL] [Abstract][Full Text] [Related]
5. Silent HIV infection. Aiuti F; Ensoli F; Fiorelli V; Mezzaroma I; Pinter E; Guerra E; Varani AR Vaccine; 1993; 11(5):538-41. PubMed ID: 8488706 [TBL] [Abstract][Full Text] [Related]
6. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Zubler RH; Perrin LH; Doucet A; Zhang X; Huang YP; Miescher PA Clin Exp Immunol; 1992 Jan; 87(1):31-6. PubMed ID: 1733635 [TBL] [Abstract][Full Text] [Related]
7. Pokeweed mitogen-stimulated peripheral blood mononuclear cells from at-risk seronegative subjects produce in vitro HIV-1-specific antibodies. Fiore JR; Angarano G; Fico C; Quarto M; Congedo P; di Stefano M; Grottola A; Monno L; Germinario C; Fontana A AIDS; 1991 Aug; 5(8):1034-6. PubMed ID: 1777168 [No Abstract] [Full Text] [Related]
8. B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. Amadori A; Zamarchi R; Veronese ML; Panozzo M; Mazza MR; Barelli A; Borri A; Chieco-Bianchi L AIDS; 1991 Jul; 5(7):821-8. PubMed ID: 1909874 [TBL] [Abstract][Full Text] [Related]
9. Detection of human immunodeficiency virus type 1 by PCR before seroconversion in high-risk individuals who remain seronegative for prolonged periods. Gorriño MT; Campelo C; Suarez MD; Santamaría A; Malave C; Cisterna R Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):271-6. PubMed ID: 8050445 [TBL] [Abstract][Full Text] [Related]
10. Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. MacGregor RR; Dubin G; Frank I; Hodinka RL; Friedman HM Clin Infect Dis; 1995 Jul; 21(1):122-7. PubMed ID: 7578720 [TBL] [Abstract][Full Text] [Related]
11. Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters. Keay S; Wecksler W; Wasserman SS; Margolick J; Farzadegan H J Infect Dis; 1995 Feb; 171(2):312-9. PubMed ID: 7844366 [TBL] [Abstract][Full Text] [Related]
12. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029 [TBL] [Abstract][Full Text] [Related]
13. Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. Romano L; Catucci M; De Milito A; Venturi G; Zazzi M; Almi P; Gonnelli A; Rubino M; Maestrini R; Valensin PE Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):1011-14. PubMed ID: 8654439 [TBL] [Abstract][Full Text] [Related]
14. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730 [TBL] [Abstract][Full Text] [Related]
15. Absence of prolonged immunosilent infection with human immunodeficiency virus in individuals with high-risk behaviors. Coutlée F; Olivier C; Cassol S; Voyer H; Kessous-Elbaz A; Saint-Antoine P; He Y; Fauvel M Am J Med; 1994 Jan; 96(1):42-8. PubMed ID: 8304362 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Terpstra FG; Al BJ; Roos MT; De Wolf F; Goudsmit J; Schellekens PT; Miedema F Eur J Immunol; 1989 Apr; 19(4):667-73. PubMed ID: 2567244 [TBL] [Abstract][Full Text] [Related]
17. Early detection of human immunodeficiency virus type 1-specific B-lymphocyte-derived antibodies in a high-risk population. Odinsen O; Parker D; Radebe F; Guness M; Lewis DA Clin Vaccine Immunol; 2009 Jul; 16(7):1060-5. PubMed ID: 19474262 [TBL] [Abstract][Full Text] [Related]
18. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Pantaleo G; De Maria A; Koenig S; Butini L; Moss B; Baseler M; Lane HC; Fauci AS Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4818-22. PubMed ID: 2112749 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. Jackson JB; Kwok SY; Sninsky JJ; Hopsicker JS; Sannerud KJ; Rhame FS; Henry K; Simpson M; Balfour HH J Clin Microbiol; 1990 Jan; 28(1):16-9. PubMed ID: 2298875 [TBL] [Abstract][Full Text] [Related]